Jenscare Scientific Co., Ltd.

Wishing a happy new year to dear all, and looking forward to new adventures and wonderful achievements in 2025! 😃

May this Christmas season bring you endless joy, love, and the warmth of cherished moments. Merry Christmas!

Exciting to see LuX-Valve Plus shine at the #APCASH 2024 conference in Hong Kong! The innovative #TTVR technology continues to make waves, delivering exceptional clinical outcomes, especially for high-risk surgical patients. The latest clinical data and case studies highlight the device's safety, efficacy, and the transformative potential of transjugular access. Also proud to see LuX-Valve Plus paving the way for a brighter future in tricuspid valve treatment. #APCASH #TTVR #LuXValvePlus #RVRV #TheRightValveforRightVentricle #Cardiology #StructuralHeart #MedicalInnovation #AsiaPacific  

During the PCR London Valves 2024 conference, the advantages of the transjugular approach took center stage. A big thank you to Kent Chak Yu So and Vinicius Esteves for highlighting the benefits of this innovative access technique when using LuX-Valve Plus. 💡 Key benefits discussed: • Reduced procedural risks • Shortened surgery times • Enhanced efficiency with low complications   This approach, combined with the advanced design of LuX-Valve Plus, marks a step forward in delivering safe and efficient tricuspid valve treatments. We are grateful to the global experts contributing to this vital discussion! #PCRLV2024 #LuXValvePlus #RVRV #TheRightValveforRightVentricle

Get ready for the APCASH 2024! We'll be sharing groundbreaking insights on Trans-Jugular TTVR using the LuX-Valve Plus, including one-year clinical outcomes and a recorded case study. ✨ Stay tuned for more updates as we dive into the latest advancements in structural heart interventions and explore how the LuX-Valve Plus is transforming patient care. 📅 Don't miss out! #APCASH #TTVR #LuXValvePlus #RVRV #TheRightValveforRightVentricle #Cardiology #StructuralHeart #MedicalInnovation #AsiaPacific

At the PCR London Valves conference, clinicians from Europe, Hong Kong, and Brazil, including Rodrigo Estévez Loureiro, MD, PhD, FESC , Simon Lam and Vinicius Esteves shared their valuable insights and experiences with LuX-Valve Plus. 💡Highlights included: • Success in treating patients with large annuli • Low pacemaker implantation rates, emphasizing the safety of the procedure • Positive outcomes in complex tricuspid cases across diverse healthcare systems A sincere thank you to all the experts who are shaping the future of tricuspid valve therapy with their inspiring work. #PCRLV2024 #LuXValvePlus #RVRV #TheRightValveforRightVentricle

At the PCR London Valves conference, we had the privilege of hearing from leading clinicians and researchers from around the world who are advancing the field of transcatheter tricuspid valve replacement (TTVR). 💡A key highlight shared by thomas modine was the one-year follow-up data from the Travel II study, which showcased that LuX-Valve Plus is expected to effectively reduce tricuspid regurgitation (TR), improve heart function, and present safety outcomes for patients with large tricuspid annuli. We are honored to be part of these advancements and look forward to continued collaboration with global experts in the field. #PCRLV2024 #LuXValvePlus #RVRV #TheRightValveforRightVentricle

Muchas gracias al profesor Rodrigo por la maravillosa operación LuX-Valve Plus en PCR London valves. Rodrigo Estévez Loureiro, MD, PhD, FESC The combination of actual cases vividly demonstrates the design features of LuX-Valve Plus and its ability to the unmet clinical needs. Hope this device can continue to bring better clinical benefits and improve the quality of life for patients in future. #LuXValvePlus #TTVR #PCRLV2024 #RVRV #TheRightValveforRightVentricle

Obrigado pela sua partilha profissional. Really looking forward to it. 😀

Thanks for this excellent experience, really helpful and practical!👍